Kopran Ltd receives UK MHRA Good Manufacturing Practices certification

Kopran Ltd announced that the the UK, Medicines andHealthcare products Regulatory Agency (UK MHRA) has granted the certificate of compliance with principles and guidelines of good manufacturing practice (GMP) for the finished dosage forms facility located at Khalapur, Khopoli (Maharashtra), manufacturing general capsules arid tablets.

Kopran is the group company of Parijat enterprises and is currently an integrated Pharmaceutical Company manufacturing a large range of products. It manufactures both Active Pharmaceutical Ingredients (API’s) and Finished Dosage Forms. The company is focused on improvement in technology and new products duly integrated through their sophisticated Research & Development department.

The company believes that the approval for this facility will enable Kopran to supply finished dosage forms to the UK and the European market for which necessary marketing tie-ups are being entered into. The facility also has approvals from regulatory authorities of several countries all over the world including the Medicines Control Council (MCC) of South Africa and the Therapeutic Goods Administration (TGA) of Australia.